Non-Hodgkin's Lymphoma Presenting as Anasarca: Probably Mediated by Tumor Necrosis Factor Alpha (TNF-α)

Anand P. Jillella Section of Hematology/Oneology, Department of Medicine, Medical College of Georgia, Augusta, GA, 30912, USACorrespondence[email protected]

D. Scott Day Department of Pathology, Medical College of Georgia, Augusta, GA, 30912, USA

Kathirae Severson Section of Hematology/Oneology, Department of Medicine, Medical College of Georgia, Augusta, GA, 30912, USA

Andre M. Kallab Section of Hematology/Oneology, Department of Medicine, Medical College of Georgia, Augusta, GA, 30912, USA

Russell Burgess Section of Hematology/Oneology, Department of Medicine, Medical College of Georgia, Augusta, GA, 30912, USA

References

Garland T, Jr, Graber S E, Stein R S. Lymphoma presenting as anasarca. Southern Medical Journal 1981; 74: 1157–1158
PubMed Web of Science ®Google Scholar
Moreb J, Ricardo E, Duque R E, Siddique T, McCarley D L, Braylan R C. High-grade B-cell lymphoma presenting as polyserosal disease: Diagnosis by flow cytometry. Cancer 1989; 64: 2254–2258
PubMed Web of Science ®Google Scholar
Puri R K, Rosenberg S A. Combined effects of Interferon a and Interleukin 2 on the induction of a vascular leak syndrome in mice. Cancer Immunology Immunotherapy 1989; 28: 267–274
PubMed Web of Science ®Google Scholar
Cotran R S, Pober J S, Gimbrone M A, Springer T A, Wiebke E A, Gaspari A A, Rosenberg S A, Lotze M T. Endothelial activation during Interleukin 2 immunotherapy: A possible mechanism for the vascular leak syndrome. Journal of Immunology 1987; 139: 1883–1888
Google Scholar
Royall J A, Berkow R L, Beckman J S, Cunningham M K, Matalon S, Freeman B A. Tumor necrosis factor and interleukin la increase vascular endothelial permeability. American Journal of Physiology 1989; 257: 399–410
PubMed Web of Science ®Google Scholar
Salles G, Bienvenu J, Bastion Y, Barbier Y, Doche C, Krzysztof W, Gutowski M C, Rieux C, Coiffier B. Elevated circulating levels of TNFα and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. British Journal of Haematology 1996; 93: 352–359
PubMed Web of Science ®Google Scholar
Warzocha K, Salles G, Bienvenu J, Barbier Y, Bastion Y, Doche C, Rieux C, Coiffier B. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas. Leukemia 1997; 11: 441–443
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Non-Hodgkin's Lymphoma Presenting as Anasarca: Probably Mediated by Tumor Necrosis Factor Alpha (TNF-α)

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Non-Hodgkin's Lymphoma Presenting as Anasarca: Probably Mediated by Tumor Necrosis Factor Alpha (TNF-α)

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date